Level Four Advisory Services’s Corcept Therapeutics CORT Stock Holding History

Level Four Advisory Services’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$328K	Buy	+2,844	New	+$306K	0.01%	734

Other funds holding CORT

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Ingalls & Snyder LLC New York $3.91B AUM 60.54% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Level Four Advisory Services's CORT Position: Q3 2026 in Review

Level Four Advisory Services opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 2,844 shares worth $328K. The stake represents 0.01% of the portfolio and ranks #734 among its holdings.

403 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

Level Four Advisory Services held 2,844 shares of Corcept Therapeutics worth $328K as of Q3 2026.
Corcept Therapeutics was a new Level Four Advisory Services position in Q3 2026.
Corcept Therapeutics made up 0.01% of Level Four Advisory Services's portfolio in Q3 2026, its #734 holding.
403 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Level Four Advisory Services's 13F filing for Q3 2026, filed 6 Nov 2026.